Performance of two new, automated chemiluminescence assay panels for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome

International Journal of Laboratory Hematology

Volumn 34, Issue 6, 2012, Pages 630-640

  Van Hoecke, F ^a   Persijn, L ^a   Decavele, A S ^a   Devreese, Katrien ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Anti beta2 glycoprotein I antibodies; Anticardiolipin antibodies; Antiphospholipid syndrome; ELISA; HemosIL acustar analyser; Thrombosis; Zenit RA analyser

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M ANTIBODY; PROTEIN ANTIBODY; ANTIBODY; IMMUNOGLOBULIN M;

ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; ARTICLE; BLOOD CLOTTING; CHEMILUMINESCENCE ANALYZER; CHEMILUMINESCENCE IMMUNOASSAY; CLINICAL ARTICLE; COHORT ANALYSIS; CORRELATION COEFFICIENT; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LABORATORY AUTOMATION; LABORATORY DIAGNOSIS; PARTIAL THROMBOPLASTIN TIME; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; THROMBOCYTE POOR PLASMA; VEIN THROMBOSIS; BLOOD; IMMUNOLOGY; LUMINESCENCE; PROCEDURES; REPRODUCIBILITY;

ANTIBODIES; ANTIBODIES, ANTICARDIOLIPIN; ANTIPHOSPHOLIPID SYNDROME; AUTOMATION, LABORATORY; BETA 2-GLYCOPROTEIN I; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUMINESCENT MEASUREMENTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84873291012     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2012.01448.x     Document Type: Article

References (29)

1. Miyakis S, Lockshin MD, Atsumi D, Branch DW, Brey RL, Cervera R, Derksen RHWM, deGroot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA. International consensus statement on a update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306.
2. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, Brey R, Derksen R, Harris EN, Hughes GR, Triplett DA, Khamashta MA. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999;42:1309- 11.
3. Devreese K, Hoylaerts MF. Laboratory diagnosis of the antiphospholipid syndrome: a plethora of obstacles to overcome. Eur J Haematol 2009;83:1-16.
4. Urbanus RT, de Groot PG. Antiphospolipid antibodies - We are not quite there yet. Blood Rev 2011;25:97-106.
5. Giannakopoulos B, Krilis SA. How we treat the antiphospholipid syndrome. Blood 2009;114:2020-30.
6. Reber G, Tincani A, Sanmarco M, deMoerloose P, Boffa MC. Proposals for the measurement of anti-beta2-glycoprotein I antibodies. Standardization group of the European Forum on Antiphospolipid Antibodies. J Thromb Haemost 2004;2:1860-2.
7. Tincani A, Allegri F, Balestrieri G, Reber G, Sanmarco M, Meroni P, Boffa MC. Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies. Thromb Res 2004;114:553-8.
8. Tincani A, Filippini M, Scarsi M, Galli M, Meroni PL. European attempts for the standardisation of the antiphospholipid antibodies. Lupus 2009;18:913-19.
9. Decavele AS, Schouwers S, Devreese KM. Evaluation of three commercial ELISA kits for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome. Int J Lab Hematol 2011;33:97-108.
10. Pengo V, Tripodi A, Reber G, Rand JH, Ortel TL, Galli M, deGroot PG. Update of the guidelines for lupus anticoagulant detection Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost 2009;7:1737-40.
11. Persijn L, Decavele AS, Schouwers S, Devreese K. Evaluation of a new set of automated chemiluminescense assays for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome. Thromb Res 2011;128:565-9.
12. de Moerloose P, Reber G, Musial J, Arnout J. Analytical and clinical performance of a new, automated assay panel for the diagnosis of antiphospholipid syndrome. J Thromb Haemost 2010;16:1540-6.
13. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update On behalf of the Subcommittee on Lupus Anticoagulant/ Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost 1995;74: 1185-90.
14. Devreese KM, Van Hoecke F. Anticardiolipin and anti-b2glycoprotein-I antibody cutoff values in the diagnosis of antiphospholipid syndrome: more than calculating the in-house 99th percentiles, even for new automated assays. Thromb Res 2011;128: 598-600.
15. Pengo V. Antiphospholipid syndrome: interpretation of laboratory data. J Thromb Haemost 2011;9:402-3.
16. Pengo V. A contribution to the debate on the laboratory criteria that define the antiphospholipid syndrome. J Thromb Haemost 2008;6:1048-9.
17. Ichikawa K, Tsutsumi A, Atsumi T, Matsuura E, Kobayashi S, Hughes GR, Khamashta MA, Koike T. A chimeric antibody with the human gamma1 constant region as a putative standard for assays to detect IgG beta2-glycoprotein I-dependent anticardiolipin and anti-beta2-glycoprotein I antibodies. Arthritis Rheum 1999;42:2461 -70.
18. Devreese K, Peerlinck K, Hoylaerts MF. Thrombotic risk assessment in the antiphospholipid syndrome requires more than the quantification of lupus anticoagulants. Blood 2010;115:870-8.
19. Favaloro EJ. Standardization, regulation, quality assurance and emerging technologies in hemostasis: issues, controversies, benefits and limitations. Semin Thromb Hemost 2007;33:290-7.
20. Pengo V, Biasiolo A, Bison E, Chantarangkul V, Tripodi A. On behalf of the participating centres of the Italian Federation of Anticoagulation Clinics (FCSA) Antiphospholipid antibody ELISAs: survey on the performance of clinical laboratories assessed by using lyophilized affinity-purified IgG with anticardiolipin and anti-β2- glycoprotein I activity. Thromb Res 2007;120:127-33.
21. Galli M, Reber G, deMoerloose P, deGroot PG. Invitation to debate on the serological criteria that define the antiphospholipid syndrome. J Thromb Haemost 2008;6:399- 401.
22. Lakos G, Favaloro EJ, Harris EN, Meroni PL, Tincani A, Wong RC, Pierangeli SS. International consensus guidelines on anticardiolipin and anti-β2glycoprotein I testing: a report from the APL Task Force at the 13th international congress on antiphospholipid antibodies. Arthritis Rheum 2012;64:1-10.
23. Danowski A, deAzevedo MN, deSouza Papi JA, Petri M. Determinants of risk for venous and arterial thrombosis in primary antiphospholipd syndrome and in anti^hospholipid syndrome with systemic lupus erythematosus. J Rheumatol 2009;36:1195-9.
24. Galli M, Borrelli G, Jacobsen EM, Marfisi RM, Finazzi G, Marchioli R, Wisloff F, Marziali S, Morboeuf O, Barbui T. Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the Antiphospholipid syndrome) study. Blood 2007;110:1178-83.
25. Naess IA, Christiansen SC, Cannegieter SC, Rosendaal FR, Hammerstroem J. A prospective study of anticardiolipin antibodies as a risk factor for venous thrombosis in a general population (the HUNT study). J Thromb Haemost 2006;4:44-9.
26. Zoghlami-Rintelen C, Vormittag R, Sailor T, Lehr S, Quehenberger P, Rumpold H, Male C, Pabinger I. The presence of IgG antibodies against beta-2-glycoprotein I predicts the risk of thrombosis in patients with lupus anticoagulant. J Thromb Haemost 2005;3:1160-5.
27. Devreese K, Peerlinck K, Hoylaerts MF. Diagnostic test combinations associated with thrombosis in lupus anticoagulant positive patients. J Thromb Haemost 2011;105:736-8.
28. Pierangeli SS, Harris EN. A protocol for determination of anticardiolipin antibodies by ELISA. Nat Protoc 2008;3:840-8.
29. Reber G, Tincani A, Sanmarco M, deMoerloose P, Boffa MC. European Forum on Antiphospholipid Antibodies Standardization Group Variability of anti-beta2 glycoprotein I antibodies measurement by commercial assays. J Thromb Haemost 2005;94:665-72.